Arch Virol
- KIM HJ, Park JG, Moon KS, Jung SB, et al
Identification and characterization of a marine bacterium extract from Mameliella
sp. M20D2D8 with antiviral effects against influenza A and B viruses.
Arch Virol. 2024;169:41.
Biochemistry
- TOWNSEND JA, Fapohunda O, Wang Z, Pham H, et al
Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus
VP4, and HIV Vpu.
Biochemistry. 2024;63:241-250.
BMC Pediatr
- AKHTAR S, Anis I, Kumar NA, Ihsan MT, et al
Assessing pattern of the Pediatric Multisystem Inflammatory Syndrome (PMIS) in
children during the COVID-19 pandemic: experience from the emergency department
of tertiary care center of a low-middle-income country.
BMC Pediatr. 2024;24:98.
- ABUSHAHIN A, Toma H, Alnaimi A, Abu-Hasan M, et al
Impact of COVID?19 pandemic restrictions and subsequent relaxation on the
prevalence of respiratory virus hospitalizations in children.
BMC Pediatr. 2024;24:91.
- BAKHTIARI E, Moazzen N
Pulmonary function in children post -SARS-CoV-2 infection: a systematic review
and meta-analysis.
BMC Pediatr. 2024;24:87.
BMJ
- FELDMAN JM, Bassett MT
US public health after covid-19: learning from the failures of the hollow state
and racial capitalism.
BMJ. 2024;384:e076969.
- MORRISON JS, Gayle HD
After covid-19: the case for optimism for US leadership in global health.
BMJ. 2024;384:q138.
- WISE J
Covid inquiry: Tears and tensions as Sturgeon takes the stand.
BMJ. 2024;384:q289.
- LADDS E, Darbyshire JL, Bakerly ND, Falope Z, et al
Cognitive dysfunction after covid-19.
BMJ. 2024;384:e075387.
Cell
- QU P, Xu K, Faraone JN, Goodarzi N, et al
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip
variants.
Cell. 2024;187:585-595.
- ZHANG L, Kempf A, Nehlmeier I, Cossmann A, et al
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high
efficiency.
Cell. 2024;187:596-608.
Epidemiol Infect
- ROSNER BM, Falkenhorst G, Kumpf I, Enssle M, et al
Case-control study of behavioural and societal risk factors for sporadic
SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
Epidemiol Infect. 2024;152:e16.
J Gen Virol
- HARDISTY G, Nicol MQ, Shaw DJ, Bennet ID, et al
Latent gammaherpesvirus infection enhances type I IFN response and reduces virus
spread in an influenza A virus co-infection model.
J Gen Virol. 2024;105.
J Immunol
- DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against
Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and
Syrian Golden Hamster Models.
J Immunol. 2024;212:576-585.
- BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting
Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
J Immunol. 2024;212:523-528.
- TANDON P, Abrams ND, Avula LR, Carrick DM, et al
Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
J Immunol. 2024;212:505-512.
J Infect
- MURRAY JM, Murray DD, Schvoerer E, Akand EH, et al
SARS-CoV-2 Delta and Omicron community transmission networks as added value to
contact tracing.
J Infect. 2024 Jan 17:S0163-4453(24)00023-9. doi: 10.1016/j.jinf.2024.
- CORNISH EF, van der Meeren LE, van der Hoorn MP, Schoenmakers S, et al
Stillbirths due to placental COVID infection associated with chronic histiocytic
intervillositis do not recur in subsequent pregnancies.
J Infect. 2024 Jan 11:S0163-4453(24)00020-3. doi: 10.1016/j.jinf.2024.
- ZHANG H, Zhou K, Peng F, Gao Z, et al
Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar
antiviral potency.
J Infect. 2024 Jan 6:S0163-4453(23)00600-X. doi: 10.1016/j.jinf.2023.
- ZONG K, Yuan P, Wang R, Luo Q, et al
Characteristics of innate, humoral and cellular immunity in children with
non-severe SARS-CoV-2 infection.
J Infect. 2023 Dec 13:S0163-4453(23)00589-3. doi: 10.1016/j.jinf.2023.
- FERNANDEZ-DE-LAS-PENAS C, Notarte KI, Macasaet R, Velasco JV, et al
Persistence of post-COVID symptoms in the general population two years after
SARS-CoV-2 infection: A systematic review and meta-analysis.
J Infect. 2023 Dec 13:S0163-4453(23)00590-X. doi: 10.1016/j.jinf.2023.
- STRAHM C, Kahlert CR, Gusewell S, Vuichard-Gysin D, et al
Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC)
after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker
cohort.
J Infect. 2023 Dec 7:S0163-4453(23)00588-1. doi: 10.1016/j.jinf.2023.
- GRAU S, Vela JM, Gurt A, Barcelo-Vidal J, et al
Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild
symptomatic COVID-19 patients.
J Infect. 2023 Nov 20:S0163-4453(23)00562-5. doi: 10.1016/j.jinf.2023.
- DIEP AN, Schyns J, Gourzones C, Goffin E, et al
How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity
dynamics: an 18-month longitudinal study.
J Infect. 2023 Nov 17:S0163-4453(23)00558-3. doi: 10.1016/j.jinf.2023.
J Infect Dis
- MUNOZ-QUILES C, Lopez-Lacort M, Urchueguia A, Diez-Domingo J, et al
Risk of cardiovascular events after influenza: A population-based Self Controlled
Case Series study, Spain 2011-2018.
J Infect Dis. 2024 Feb 8:jiae070. doi: 10.1093.
J Virol
- YANG Q, Barbachano-Guerrero A, Fairchild LM, Rowland TJ, et al
Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a
high-fidelity cellular model for investigating HIV-1, dengue, and influenza
viruses.
J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563.
- SHINGAI M, Iida S, Kawai N, Kawahara M, et al
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon
influenza virus infection by subtraction of the background antibody repertoire.
J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
JAMA
- NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
JAMA. 2024;331:396-407.
- FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2
Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA. 2024;331:408-416.
- RUBIN R
As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2
"Variant of Interest".
JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
- RUBIN R
From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent
Respiratory Disease Surges.
JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
Lancet
- MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic:
planning, outcomes, and lessons learnt.
Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
MMWR Morb Mortal Wkly Rep
- LINK-GELLES R, Ciesla AA, Mak J, Miller JD, et al
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine
Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to
Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing
Community Access to Testing Pro
MMWR Morb Mortal Wkly Rep. 2024;73:77-83.
PLoS One
- WANG Y, Livingston M, McArthur DP, Bailey N, et al
Enhancing our understanding of short-term rental activity: A daily scrape-based
approach for Airbnb listings.
PLoS One. 2024;19:e0298131.
- MANEEJUK P, Sukinta P, Chinkarn J, Yamaka W, et al
Does the resumption of international tourism heighten COVID-19 transmission?
PLoS One. 2024;19:e0295249.
- COZEN AE, Carton T, Hamad R, Kornak J, et al
Factors associated with anxiety during the first two years of the COVID-19
pandemic in the United States: An analysis of the COVID-19 Citizen Science study.
PLoS One. 2024;19:e0297922.
- MALM KL, Peprah NY, Mohammed W, Adomako BY, et al
A retrospective analysis of malaria deaths in the pre- and intra- COVID 19
pandemic era, Ghana, 2016-2021.
PLoS One. 2024;19:e0286212.
- GARENNE M, Stiegler N
Covid-19 demography in France and South Africa: A comparative study of morbidity
and mortality in 2020-2022.
PLoS One. 2024;19:e0294870.
- MENNIS E, Hobus M, van den Muijsenbergh M, van Loenen T, et al
COVID-19 related morbidity and mortality in people experiencing homelessness in
the Netherlands.
PLoS One. 2024;19:e0296754.
- CAMPOS RP, Messias Oliveira JG, de Oliveira Farias I, de Souza VCV, et al
Effects of pulmonary rehabilitation on ventilation dynamics measured during
exertion in patients with post-acute COVID-19 syndrome: A cross-sectional
observational study.
PLoS One. 2024;19:e0296707.
- LIU CC, Ling J, Zahry NR, Liu C, et al
Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions
and behavior among international and domestic college students in the United
States.
PLoS One. 2024;19:e0293130.
- RICHARDSON L, Long E, Goodfellow C, Milicev J, et al
Starting an undergraduate degree amid the COVID-19 pandemic: A mixed-method
egocentric network study on student loneliness.
PLoS One. 2024;19:e0297953.
- FEIFEI F
Analyzing metaphor patterns in COVID-19 news pictures: A critical study in China.
PLoS One. 2024;19:e0297336.
- STONE H, Bailey E, Wurie H, Leather AJM, et al
A qualitative study examining the health system's response to COVID-19 in Sierra
Leone.
PLoS One. 2024;19:e0294391.
- YANG Y, Liu B, Wen YJ, Li ZJ, et al
Fever clinic construction and management targeted to prevention and control of
healthcare-associated respiratory viral infections in Jiangsu, China: A
cross-sectional observational study.
PLoS One. 2024;19:e0297133.
- DUO H, Jin M, Yang Y, Baheti R, et al
Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with
meta-analysis and trial sequential analysis.
PLoS One. 2024;19:e0297628.
- WANG Q, Gu H, Ren J, Zhao Y, et al
Analysis of characteristics of and risk factors for otological symptoms after
COVID-19 infection.
PLoS One. 2024;19:e0297100.
- MCQUILLAN K, Yoshida-Montezuma Y, Jambon M, Vanderloo LM, et al
Physical activity and unexpected weight change in Ontario children and youth
during the COVID-19 pandemic: A cross-sectional analysis of the Ontario Parent
Survey 2.
PLoS One. 2024;19:e0292934.
- UDOAKANG AJ, Nganyewo NN, Djomkam Zune AL, Olwal CO, et al
Knowledge, attitude and perception towards COVID-19 among representative educated
sub-Saharan Africans: A cross-sectional study during the exponential phase of the
pandemic.
PLoS One. 2024;19:e0281342.
- GAO ZH, Li J
Intolerance of uncertainty and mental health in China "Post-pandemic" age: The
mediating role of difficulties in emotion regulation.
PLoS One. 2024;19:e0298044.
- GHADER N, AlMheiri N, Fikri A, AbdulRazzak H, et al
Prevalence and factors associated with mental illness symptoms among school
students post lockdown of the COVID-19 pandemic in the United Arab Emirates: A
cross-sectional national study.
PLoS One. 2024;19:e0296479.
- RIBEIRO M, Azevedo L, Santos AP, Pinto Leite P, et al
Understanding spatiotemporal patterns of COVID-19 incidence in Portugal: A
functional data analysis from August 2020 to March 2022.
PLoS One. 2024;19:e0297772.
Proc Natl Acad Sci U S A
- ZHAO G, Xue L, Geisler HC, Xu J, et al
Precision treatment of viral pneumonia through macrophage-targeted lipid
nanoparticle delivery.
Proc Natl Acad Sci U S A. 2024;121:e2314747121.
- ZHANG Y, Bharathi V, Dokoshi T, de Anda J, et al
Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that
reassemble into proinflammatory supramolecular complexes.
Proc Natl Acad Sci U S A. 2024;121:e2300644120.
- PAGLINO E, Lundberg DJ, Wrigley-Field E, Zhou Z, et al
Excess natural-cause mortality in US counties and its association with reported
COVID-19 deaths.
Proc Natl Acad Sci U S A. 2024;121:e2313661121.
Vaccine
- STELETOU E, Giannouchos T, Dimitriou G, Karatza A, et al
Parental concerns and vaccine hesitancy against COVID-19 vaccination for children
in Greece: A cross-sectional survey.
Vaccine. 2024 Jan 6:S0264-410X(24)00003-3. doi: 10.1016/j.vaccine.2024.
- FILIPAS DK, Labban M, Beatrici E, Stone BV, et al
Exploring preventive care practices among unvaccinated individuals in the United
States during the COVID-19 pandemic.
Vaccine. 2024;42:441-447.
- KRANZLER EC, Ihongbe TO, Marshall MC, Denison B, et al
Racial and ethnic differences in COVID-19 vaccine readiness among adults in the
United States, January 2021-April 2023.
Vaccine. 2024 Jan 4:S0264-410X(23)01537-2. doi: 10.1016/j.vaccine.2023.
- BUHL C, Jacobsen R, Almarsdottir AB, Abtahi S, et al
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with
thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A
cross-sectional study in six EU member states.
Vaccine. 2024 Jan 4:S0264-410X(23)01511-6. doi: 10.1016/j.vaccine.2023.
- CHARPIGNON ML, Gupta S, Shahnaz Majumder M
Massachusetts companion program bolsters COVID-19 vaccine rates among seniors.
Vaccine. 2024 Jan 3:S0264-410X(23)01494-9. doi: 10.1016/j.vaccine.2023.
- DAVIDSON AM, Burns S, White LA, Perlman M, et al
"I shall not poison my child with your human experiment": Investigating
predictors of parents' hesitancy about vaccinating younger children (<12) in
Canada.
Vaccine. 2024 Jan 2:S0264-410X(23)01519-0. doi: 10.1016/j.vaccine.2023.
- AGASSE E, Rodriguez GF, Vilarino V, Galli JH, et al
Social determinants of health and vaccine uptake in pregnancy: Disparities in a
diverse, predominately foreign-born population.
Vaccine. 2024 Jan 2:S0264-410X(23)01515-3. doi: 10.1016/j.vaccine.2023.
- RUBIO-CASILLAS A, Rodriguez-Quintero CM, Redwan EM, Gupta MN, et al
Do vaccines increase or decrease susceptibility to diseases other than those they
protect against?
Vaccine. 2023 Dec 28:S0264-410X(23)01506-2. doi: 10.1016/j.vaccine.2023.
- SHENTON P, Schrader S, Smith J, Alafaci A, et al
Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in
Victoria, Australia: A clinical surveillance study.
Vaccine. 2023 Dec 27:S0264-410X(23)01516-5. doi: 10.1016/j.vaccine.2023.
- NGUYEN KH, Coy KC, Black CL, Scanlon P, et al
Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general
in the USA.
Vaccine. 2023 Dec 23:S0264-410X(23)01488-3. doi: 10.1016/j.vaccine.2023.
- KACHKO A, Selvaraj P, Liu S, Kim J, et al
Vaccine-associated respiratory pathology correlates with viral clearance and
protective immunity after immunization with self-amplifying RNA expressing the
spike (S) protein of SARS-CoV-2 in mouse models.
Vaccine. 2023 Dec 22:S0264-410X(23)01498-6. doi: 10.1016/j.vaccine.2023.
- LO E, Brousseau N, Defay F, Fortin E, et al
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in
Quebec, Canada, during the Delta and early Omicron periods.
Vaccine. 2023 Dec 22:S0264-410X(23)01489-5. doi: 10.1016/j.vaccine.2023.
- KURIYAMA K, Murakami K, Sugiura K, Sakui S, et al
Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373
(TAK-019) in healthy Japanese adults who had previously received a primary series
of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial.
Vaccine. 2023 Dec 20:S0264-410X(23)01482-2. doi: 10.1016/j.vaccine.2023.
- WOLFF M, Charpentier P, Canals A, Vial C, et al
Humoral immune response in people living with HIV after administration of
SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence:
A cross-sectional study.
Vaccine. 2023 Dec 19:S0264-410X(23)01481-0. doi: 10.1016/j.vaccine.2023.
- ARASHIRO T, Miwa M, Nakagawa H, Takamatsu J, et al
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy,
invasive mechanical ventilation, and death in Japan: A multicenter case-control
study (MOTIVATE study).
Vaccine. 2023 Dec 18:S0264-410X(23)01480-9. doi: 10.1016/j.vaccine.2023.
Virology
- YANG J, Lan R, Chang H, Li H, et al
Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza
virus in pigs suffering from pneumonia.
Virology. 2024;592:110009.
Virus Res
- LI ZA, Bajpai AK, Wang R, Liu Y, et al
Systems Genetics of Influenza A Virus-infected Mice Identifies TRIM21 as a
Critical Regulator of Pulmonary Innate Immune Response.
Virus Res. 2024 Feb 6:199335. doi: 10.1016/j.virusres.2024.199335.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016